These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19711445)

  • 1. Combined application of high resolution and tandem mass spectrometers to characterize methionine oxidation in a parathyroid hormone formulation.
    Pan C; Valente JJ; LoBrutto R; Pickett JS; Motto M
    J Pharm Sci; 2010 Mar; 99(3):1169-79. PubMed ID: 19711445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn.
    Modhave DT; Handa T; Shah RP; Singh S
    J Pharm Biomed Anal; 2011 Nov; 56(3):538-45. PubMed ID: 21757313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
    Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
    J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
    Tiwari RN; Bonde CG
    J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modes of Degradation and Impurity Characterization in rhPTH (1-34) during Stability Studies.
    Kothari R; Kumar V; Jena R; Tunga R; Tunga BS
    PDA J Pharm Sci Technol; 2011; 65(4):348-62. PubMed ID: 22293522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
    Wu Y
    Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
    Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
    J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multidisciplinary approach to identify a degradation product in a pharmaceutical dosage form.
    Pan C; Guan J; Lin M
    J Pharm Biomed Anal; 2011 Mar; 54(4):855-9. PubMed ID: 21129882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the degradation products of a color-changed monoclonal antibody: tryptophan-derived chromophores.
    Li Y; Polozova A; Gruia F; Feng J
    Anal Chem; 2014 Jul; 86(14):6850-7. PubMed ID: 24937252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Middle-down fragmentation for the identification and quantitation of site-specific methionine oxidation in an IgG1 molecule.
    Pipes GD; Campbell P; Bondarenko PV; Kerwin BA; Treuheit MJ; Gadgil HS
    J Pharm Sci; 2010 Nov; 99(11):4469-76. PubMed ID: 20845446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide.
    Kowalik-Jankowska T; Rajewska A; Jankowska E; Wiśniewska K; Grzonka Z
    J Inorg Biochem; 2006 Oct; 100(10):1623-31. PubMed ID: 16839607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization.
    Ji JA; Zhang B; Cheng W; Wang YJ
    J Pharm Sci; 2009 Dec; 98(12):4485-500. PubMed ID: 19455640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of methionine oxidation on the aggregation of recombinant human growth hormone.
    Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T
    Eur J Pharm Biopharm; 2013 Sep; 85(1):42-52. PubMed ID: 23958317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
    Bansal G; Singh R; Saini B; Bansal Y
    J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine oxidation within the cerebroside-sulfate activator protein (CSAct or Saposin B).
    Whitelegge JP; Penn B; To T; Johnson J; Waring A; Sherman M; Stevens RL; Fluharty CB; Faull KF; Fluharty AL
    Protein Sci; 2000 Sep; 9(9):1618-30. PubMed ID: 11045609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the pyrolysis products of methionine-enkephalin-Arg-Gly-Leu using liquid chromatography-tandem mass spectrometry.
    Meetani MA; Zahid OK; Conlon JM
    J Mass Spectrom; 2010 Nov; 45(11):1320-31. PubMed ID: 20967736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual metals cause variability in methionine oxidation measurements in protein pharmaceuticals using LC-UV/MS peptide mapping.
    Zang L; Carlage T; Murphy D; Frenkel R; Bryngelson P; Madsen M; Lyubarskaya Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():71-6. PubMed ID: 22483985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril.
    Narayanam M; Sahu A; Singh S
    J Pharm Biomed Anal; 2015; 111():190-203. PubMed ID: 25890215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.